计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| O412290-1mg |
1mg |
现货 ![]() |
| |
| O412290-5mg |
5mg |
现货 ![]() |
| |
| O412290-10mg |
10mg |
现货 ![]() |
| |
| O412290-25mg |
25mg |
现货 ![]() |
|
| 别名 | OSU-T315 模拟 |
|---|---|
| 英文别名 | ILK-IN-1 |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | OSU-T315 analog |
| 生化机理 | OSU-T315 类似物(ILK-IN-1)是一种 Integrin 链接激酶(ILK)抑制剂,其 IC50 值为 0.6 μM,可通过使 AKT-Ser473 和其他 ILK 靶点(GSK-3β 和肌球蛋白轻链)去磷酸化来抑制 PI3K/AKT 信号传导。OSU-T315 可通过细胞凋亡和自噬导致细胞死亡。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 整合素连接激酶抑制剂 |
| 产品介绍 |
Information OSU-T315 analog (ILK-IN-1) is an inhibitor of Integrin-linked kinase (ILK) with IC50 of 0.6 μM which inhibits PI3K/AKT signaling by dephosphorylation of AKT-Ser473 and other ILK targets (GSK-3β and myosin light chain). OSU-T315 causes cell death through apoptosis and autophagy. |
| 纯度 | ≥98% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | N-methyl-3-[1-(4-piperazin-1-ylphenyl)-5-[4-[4-(trifluoromethyl)phenyl]phenyl]pyrazol-3-yl]propanamide |
| INCHI | 1S/C30H30F3N5O/c1-34-29(39)15-10-25-20-28(38(36-25)27-13-11-26(12-14-27)37-18-16-35-17-19-37)23-4-2-21(3-5-23)22-6-8-24(9-7-22)30(31,32)33/h2-9,11-14,20,35H,10,15-19H2,1H3,(H,34,39) |
| InChi Key | GHBUPSVATJKTRR-UHFFFAOYSA-N |
| Smiles | CNC(=O)CCC1=NN(C(=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)N5CCNCC5 |
| Isomeric SMILES | CNC(=O)CCC1=NN(C(=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)N5CCNCC5 |
| MeSH Entry Terms | N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)-1H-pyrazol-3-yl)propanamide;N-methyl-PPTBPP;OSU-T315 |
| 分子量 | 533.59 |
| Reaxy-Rn | 21888688 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=21888688&ln= |
| 分子量 | 533.600 g/mol |
|---|---|
| XLogP3 | 5.100 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 7 |
| 可旋转键计数Rotatable Bond Count | 7 |
| 精确质量Exact Mass | 533.24 Da |
| 单同位素质量Monoisotopic Mass | 533.24 Da |
| 拓扑极表面积Topological Polar Surface Area | 62.200 Ų |
| 重原子数Heavy Atom Count | 39 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 767.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 1. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S. (2000) Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells.. Proc Natl Acad Sci USA, 97 (7): (3207-12). [PMID:10716737] |
| 2. Deng JT, Van Lierop JE, Sutherland C, Walsh MP. (2001) Ca2+-independent smooth muscle contraction. a novel function for integrin-linked kinase.. J Biol Chem, 276 (19): (16365-73). [PMID:11278951] |
| 3. Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, Dedhar S. (2001) Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343.. J Biol Chem, 276 (29): (27462-9). [PMID:11313365] |
| 4. Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW, Carter JH. (2001) Integrin-linked kinase expression increases with prostate tumor grade.. Clin Cancer Res, 7 (7): (1987-91). [PMID:11448915] |
| 5. Deng JT, Sutherland C, Brautigan DL, Eto M, Walsh MP. (2002) Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase.. Biochem J, 367 (Pt 2): (517-24). [PMID:12144526] |
| 6. Ito R, Oue N, Zhu X, Yoshida K, Nakayama H, Yokozaki H, Yasui W. (2003) Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma.. Virchows Arch, 442 (2): (118-23). [PMID:12596061] |
| 7. Troussard AA, Mawji NM, Ong C, Mui A, St -Arnaud R, Dedhar S. (2003) Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation.. J Biol Chem, 278 (25): (22374-8). [PMID:12686550] |
| 8. Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, Quinn MA. (2003) Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid.. J Pathol, 201 (2): (229-37). [PMID:14517840] |
| 9. Bravou V, Klironomos G, Papadaki E, Taraviras S, Varakis J. (2006) ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway.. J Pathol, 208 (1): (91-9). [PMID:16278819] |
| 10. Schaeffer DF, Assi K, Chan K, Buczkowski AK, Chung SW, Scudamore CH, Weiss A, Salh B, Owen DA. (2010) Tumor expression of integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor snail: an immunohistochemical study in ductal pancreatic adenocarcinoma.. Virchows Arch, 456 (3): (261-8). [PMID:20091050] |
| 11. Pontier SM, Huck L, White DE, Rayment J, Sanguin-Gendreau V, Hennessy B, Zuo D, St-Arnaud R, Mills GB, Dedhar S et al.. (2010) Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer.. Oncogene, 29 (23): (3374-85). [PMID:20305688] |
| 12. Chan J, Ko FC, Yeung YS, Ng IO, Yam JW. (2011) Integrin-linked kinase overexpression and its oncogenic role in promoting tumorigenicity of hepatocellular carcinoma.. PLoS ONE, 6 (2): (e16984). [PMID:21347395] |
| 13. Lee SL, Hsu EC, Chou CC, Chuang HC, Bai LY, Kulp SK, Chen CS. (2011) Identification and characterization of a novel integrin-linked kinase inhibitor.. J Med Chem, 54 (18): (6364-74). [PMID:21823616] |
| 14. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S. (1998) Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase.. Proc Natl Acad Sci USA, 95 (19): (11211-6). [PMID:9736715] |